6 Managing fluid status in patients with suspected or confirmed COVID-19

6 Managing fluid status in patients with suspected or confirmed COVID-19

6.1 Aim to achieve and maintain optimal fluid status (euvolaemia) in all patients.

6.2 If there is volume depletion (hypovolaemia), and fluid needs cannot be met orally or enterally, give patients intravenous fluids as part of a protocol to restore and maintain optimal fluid status (see the algorithms in the NICE guideline on intravenous fluid therapy in adults in hospital).

6.3 Ensure patients have an intravenous fluid management plan that is reviewed daily.

6.4 Base choice of fluids on biochemistry results and fluid status (see the composition of commonly used crystalloids in the NICE guideline on intravenous fluid therapy in adults in hospital).

6.5 Do not routinely offer loop diuretics to treat acute kidney injury (AKI), but consider them for treating fluid overload.